KALY - Kali, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0109
-0.0003 (-2.68%)
At close: 3:53PM EST
Stock chart is not supported by your current browser
Previous Close0.0112
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume44,380,041
Market Cap12.167M
Beta (3Y Monthly)-58.00
PE Ratio (TTM)0.00
EPS (TTM)7.9550
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • USMJ Launches WWW.USMJ.COM eCommerce Site For CBD Products and Other Cannabis Essentials
    PR Newswire13 days ago

    USMJ Launches WWW.USMJ.COM eCommerce Site For CBD Products and Other Cannabis Essentials

    DALLAS , Feb. 7, 2019 /PRNewswire/ -- North American Cannabis Holdings, Inc. (USOTC: USMJ) ("USMJ") today announced launching its all new eCommerce site for CBD products and other cannabis essentials ...

  • GlobeNewswire15 days ago

    KALY – Kali-Extracts, Inc. Publishes Cannabis Extract Lung Disease Treatment Study Preview

    DALLAS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today published a preview of the recently announced long-term, pilot study on the treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates with cannabis extracts derived from Kali-Extracts patented cannabis extraction process.  The study adds to the Kali-Extracts in vitro genomics study, previously announced, to evaluate the impact of its pharmaceutical grade cannabis extracts in combination with other therapies on COPD patients.  The World Health Organization estimates 65 million people worldwide are afflicted with moderate to severe COPD and GlobalData forecasts that the COPD treatment market will reach $14.1 billion by 2025.

  • PR Newswire19 days ago

    KALY - Kali-Extracts, Inc. Announces Cannabis Extract COPD Primate Treatment Study Research Report Preview

    DALLAS , Feb. 1, 2019 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today announced a preview presentation scheduled for next week, on Tuesday, ...

  • GlobeNewswire21 days ago

    KALY Releases Update Highlighting Potential In $14 Billion COPD Treatment Market and Additional Pharmaceutical Markets

    DALLAS, Jan. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today released a corporate update that includes the latest on KALY’s developments with Puration, Inc, (PURA) (“PURA”) and Generex Biotechnology, Inc. (GNBT), the company’s research on treatments for Chronic Obstructive Pulmonary Disease (COPD), and other updates.

  • GlobeNewswire26 days ago

    KALY - Kali-Extracts COPD Research Targeting $14 Billion Treatment Market To Be Featured In Online Corporate Update Next Week

    DALLAS, Jan. 25, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced an online corporate update scheduled.

  • GlobeNewswire27 days ago

    PURA Announces Home-Grown Hemp For EVERx In Deal With KALY and NOUV

    DALLAS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Puration, Inc. (PURA) (“PURA”) today announced a home-grown source of hemp for its CBD extractions to go into its EVERx CBD Sports Water. PURA has partnered with Nouveau, Inc. (NOUV) and Kali-Extracts (KALY) to source CBD from NOUV’s hemp cultivation operation and KALY’s proprietary extraction process.

  • ACCESSWIRE27 days ago

    Best Penny Stock Plays

    HENDERSON, NV / ACCESSWIRE / January 24, 2019 / Penny and sub-penny stocks can be the biggest gainers on the market from day to day due to their low-prices. One that we like a lot is OriginClear, Inc. ...

  • GlobeNewswirelast month

    Kali-Extracts and Puration Announce First Ever 25 mg CBD Extract Formulation For Beverage Infusion

    DALLAS, Jan. 17, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) and Puration, Inc, (PURA) (“PURA”) today announced a new 25 mg CBD Extract formulation for beverage infusion.  KALY owns and manages a patented cannabis extraction process.  PURA has licensed the KALY patent for beverage infusion.  PURA currently produces EVERx CBD Sports Water infused with 10 mg of CBD.  Together KALY and PURA are designing a new private labeled CBD infused beverage for Generex Biotechnology, Inc. (GNBT).

  • GlobeNewswirelast month

    PURA Doubles EVERx CBD Sports Water Production In Reaction To Remarkable Retail Sales Redoubling $5 M Sales Goal Confidence

    DALLAS, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Puration, Inc. (USOTC: PURA) (“PURA”) today announced doubling its EVERx CBD Sports Water Production schedule in reaction to December and January retail sales.  After delivering on a record number of wholesale orders in December, PURA is already receiving re-orders in mid-January. One distributor reported selling out of its inventory and doubling the size of its next order.  “The recent retail sales reports we’ve received from distributors are nothing short of remarkable,” said Brian Shibley, CEO of Puration.

  • GlobeNewswirelast month

    PURA Introduces New EVERx CBD Sports Water Bullet Bottles After Reaching $1 Million Sales Milestone

    DALLAS, Jan. 11, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Puration, Inc. (USOTC: PURA) (“PURA”) today introduced its all new EVERx CBD Sports Water Bullet Bottles to ring in the new year. EVERx has been undergoing an all around update after reaching over a million dollars in annual sales. The EVERx logo has been refreshed, with patented cannabis extraction partner Kali-Extracts (USOTC: KALY), the EVERx formula has been improved, and with copacker partner Alkame Holdings, (USOTC: ALKM) and their new state-of-the-art bottling production line, EVERx now has an entirely new bottle.

  • GlobeNewswirelast month

    Kali-Extracts Announces Second $100,000 Hemp4mula Order For New CBD Infused Gummies

    DALLAS, Jan. 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced a $100,000 wholesale order of its new Hemp4mula CBD Infused Gummies.  The wholesale buyer recently ordered $100,000 of KALY’s Hemp4mula CBD Infused Chewing Gum.  The wholesale buyer plans to have both the Hemp4mula CBD Infused Chewing Gum and Gummies available for sale at select retail drugstore locations and through the soon to be launched USMJ E-commerce Site from North American Cannabis Holdings, Inc. (USMJ).

  • GlobeNewswirelast month

    USMJ Announces 2019 Miss USMJ Calendar Now Available For Sale Online

    North American Cannabis Holdings, Inc. (dba/USMJ) (USMJ) (“USMJ”) today announced the first ever 2019 Miss USMJ Calendar is now available for sale online at www.missusmj.com.  The Miss USMJ 2019 Calendar is not your typical pinup calendar. The calendar pictures have been artistically set to appeal to those in all stretches of the cannabis community. The Miss USMJ models were selected from open casting calls targeting the cannabis community in Colorado and California.  The Photographs were captured on location in Denver and Los Angeles by a cannabis community artist and Parsons School of Design graduate, living and working in New York City. Miss USMJ models will be participating throughout the year to help promote events for the USMJ family of companies to include Kali-Extracts (KALY) Puration (PURA) and Priority Aviation (name change pending) (PJET).

  • GlobeNewswirelast month

    Kali-Extracts Inc. Cannabis Pharmaceutical Value Highlighted In Goldman Small Cap Research Report

    “Prior to the acquisition by Kali-Extracts, NCM Biotech was engaged with a number of different universities on a number of separate research initiatives.  As an example, and as a preview of an upcoming announcement, NCM has been involved in an ongoing study with a university in Kentucky on the use of a cannabis therapy derived from Kali-Extracts’s patented extraction process for the treatment of Chronic Obstructive Pulmonary Disease (COPD).

  • GlobeNewswirelast month

    KALY - Kali-Extracts Analyst Report Published on OTCMarkets Augmenting Current Information

    DALLAS, Texas, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today published an independent analyst research report on the company following the recent acquisition of a patented cannabis extraction process. The report is available under “research” on the OTCMarkets website. The research report is the first report from Goldman Small Cap Research as part of an ongoing research engagement.

  • GlobeNewswirelast month

    KALY - New Report Notes Kali-Extracts, Inc. Has Multiple Shots on Goal in Multi-Billion Dollar Markets

    BALTIMORE, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Goldman Small Cap Research has issued a new research report on Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY). Kali, Inc. is a health and wellness company set to generate revenue from its patented cannabis extraction technology through overlapping go-to-market strategies to include the licensing of its patented cannabis extraction technology to multiple companies in the wellness and pharmaceutical industries. With promising preclinical data along with development and commercial agreements behind it, Kali-Extracts seeks to commercialize its unique and valuable IP targeting multi-billion dollar markets.

  • ACCESSWIRElast month

    Penny Stocks Set to Breakout

    HENDERSON, NV / ACCESSWIRE / January 8, 2019 / Sometimes penny and sub-penny stocks can bring savvy traders massive profits in an extremely short period of time. Due to their low price and extreme volatility ...

  • GlobeNewswirelast month

    Generex Biotechnology Introduces Treatment Alternative to $6 Billion Ulcerative Colitis Surgery Market

    MIRAMAR, Fla., Jan. 07, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE  -- Generex Biotechnology Corporation (GNBT) is pleased to announce that the company has completed the acquisition of 51% of Regentys™ Corporation, a regenerative medicine company focused on developing novel treatments for patients with gastrointestinal (GI) disorders. The terms of the deal include the previously reported upfront payment of $400,000, plus $14.6 million to be paid according to a milestone-based schedule.

  • GlobeNewswirelast month

    KALY - Kali-Extracts Analyst Research Report Featuring New Cannabis Biotechnology Business Set For Release Tomorrow

    DALLAS, Jan. 07, 2019 -- via OTC PR WIRE --  Kali, Inc. (dba/Kali-Extracts) (USOTC: KALY) (“KALY”) today confirmed the previously announced analyst research report featuring.

  • GlobeNewswire2 months ago

    GNBT – Generex Biotechnology Plans Breast Cancer Vaccine Spinout and Dividend

    MIRAMAR, Fla., Jan. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Generex Biotechnology Corporation (GNBT) is pleased to provide an update on operational and strategic developments at NuGenerex Immuno-Oncology (previously Antigen Express), a wholly-owned subsidiary. The protocol for the Phase II clinical trial of pembrolizumab (Keytruda®) in combination with the AE37 Peptide Vaccine in patients with metastatic triple negative breast cancer is under review at the Institutional Review Board (IRB) with oversight of this NSABP Foundation managed study. “With the initiation of the AE37/PD-1 Inhibitor combination trial and the advancement of the company’s clinical development partnership with Shenzhen BioScien for AE37 in prostate cancer, we have validated the Ii-Key technology, as a viable immunotherapy platform,” said Richard Purcell, SVP of R&D at Generex.

  • GlobeNewswire2 months ago

    KALY - Kali-Extracts Releases 2019 $20 Million Revenue Partnership Update

    DALLAS, Texas, Jan. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali, Inc. (dba/Kali-Extracts) (USOTC: KALY) (“KALY”) today released a 2019 New Year message published by North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) that includes an outline of KALY’s role in the partnership with the USMJ family of companies. In addition to discussing the overall objectives of the USMJ family of companies with an initial revenue goal totaling $20 million, the New Year message emphasizes that KALY has recently updated all its financial reports required by OTCMarkets to satisfy the OTCMarkets “current” filing standards and anticipates the OTCMarkets site to soon reflect KALY’s “current” filing status.

  • GlobeNewswire2 months ago

    USMJ CEO 2019 New Year Msg Outlining $20 M Revenue Goal for USMJ Family of Companies – PURA KALY PJET NOUV

    DALLAS, Jan. 04, 2019 -- via OTC PR WIRE – North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) today released a 2019 New Year message from the CEO and Chairman Steven.

  • GlobeNewswire2 months ago

    UPDATE -- Generex Biotechnology Makes Major Advance On $22 Billion Wound Care Market Announcing Milestone Agreement

    Generex Biotechnology Partner Olaregen Therapeutix Inc. Signs Manufacturing Agreements for Excellagen® Wound Healing Collagen Matrix Collagen Solutions & Berkshire Sterile.

  • GlobeNewswire2 months ago

    Kali-Extracts and Nouveau Anticipate $5 Million In Potential Revenue From Hemp Cultivation And Extraction Venture

    DALLAS, Dec. 31, 2018 -- via OTC PR WIRE -- Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) and Nouveau Life Pharmaceuticals, Inc. (dba/Nouveau, Inc) (USOTC: NOUV).

  • GlobeNewswire2 months ago

    Kali-Extracts Analyst Research Report From Goldman Small Cap Research Expected Next Week

    DALLAS, Dec. 28, 2018 -- via OTC PR WIRE --  Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced an Analyst Research Report covering the company’s new.

  • GlobeNewswire2 months ago

    Kali-Extracts Announces Strong Response To Patented Cannabis Extraction Franchise

    DALLAS, Dec. 27, 2018 -- via OTC PR WIRE -- Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced receiving a high volume of inquiries in response to.